Health

Menarini Asia-Pacific strengthens Men's Health portfolio in China with acquisition of Cialis(R) (Tadalafil) from Lilly

* Acquisition of Cialis® in the People's Republic of China to bolster Menarini's Men's Health portfolio and drive multichannel coverage * This is a significant milestone for Menarini Asia operations as it commemorates its 10th anniversary of being established in 13 major healthcare markets in...

2021-07-22 10:00 1525

Antengene Announces The Approval by Human Research Ethics Committee in Australia and to Start the Phase 1 Trial of ATG-101 (the first PD-L1/4-1BB bispecific antibody) in Solid Tumors and Non-Hodgkin Lymphoma

SHANGHAI and HONG KONG, July 22, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in hematology and oncol...

2021-07-22 09:27 1116

Joysbio's COVID-19 RAPID tests detect NEW SARS-COV-2 variants

TIANJIN, China, July 22, 2021 /PRNewswire/ -- Joysbio, one of the world's leading manufacturers of lateral flow rapid test kits, has proven that their SARS-CoV-2 (COVID-19) antigen tests can detect new variants, including the Delta variant that's sweeping the world. With over 100 million tests so...

2021-07-22 08:37 786

China NMPA Approves Phase III Clinical Trial of ASC40 Combined with Bevacizumab for Treatment of Patients with Recurrent Glioblastoma

HANGZHOU, China and SHAOXING, China, July 22, 2021 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX code: 1672) today announces that China National Medical Products Administration (NMPA) has approved the Phase III clinical trial application of ASC40 combined with Bevacizumab for treatment of patients w...

2021-07-22 08:30 1073

Sensor Technologies for Pressure Injury Prevention Improve Outcomes and Operational Efficiency for Hospitals

New solutions deliver value to hospitals by improving patient care through increased adherence to patient repositioning protocols, according to providers surveyed by Frost & Sullivan SANTA CLARA, Calif., July 22, 2021 /PRNewswire/ -- Even as the incidence of many other healthcare complications i...

2021-07-22 00:30 878

Kazia Calls for Increased Focus on Brain Cancer Research this GBM Awareness Day

SYDNEY, July 21, 2021 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), a leading drug development company in the field of brain cancer, today recognizes Glioblastoma (GBM) Awareness Day and calls for a greater focus on research from industry, academia, and government in order ...

2021-07-21 22:00 10238

AnchorDx's Non-invasive Bladder Cancer Early Detection Test, UriFind, Earns "Breakthrough Device Designation" from FDA

GUANGZHOU, China, July 21, 2021 /PRNewswire/ -- AnchorDx, a world-leading developer of cancer screening and early detection solutions, onJuly 13, 2021, was awarded aBreakthrough Device Designation ("BTD")[1] by the US Food and Drug Administration (FDA) for UriFind (or "the Test"), an early detect...

2021-07-21 21:02 1030

Hyundai Mobis develops the world's first 'brainwaves' based ADAS technology

SEOUL, South Korea, July 21, 2021 /PRNewswire/ -- After 3 years of R&D, Hyundai Mobis (KRX: 012330) finally succeeded in developing M.Brain, a new healthcare technology based on brainwave measurement. This achievement is receiving great attention for applying this brainwave measurement technology...

2021-07-21 21:00 746

ArcScan, Inc. Signs Definitive Agreement for $11.15 Million Preferred Series B Investment with Shanghai Haohai Biological Technology Ltd.

GOLDEN, Colo., July 21, 2021 /PRNewswire/ -- ArcScan, Inc., the developer of state-of-the-art ophthalmic ultrasound imaging device "ArcScan Insight® 100, " headquartered inGolden, Colorado, announces the execution of a Stock Purchase Agreement with Shanghai Haohai Biological Technology Ltd. ("Hao...

2021-07-21 20:33 7340

Augury Lauded by Frost & Sullivan for Supporting Insight-driven Manufacturing with Its Full-stack Machine Health-as-a-Service Offering

Augury's platform supports digitized collaboration and knowledge sharing, resulting in more informed decisions SANTA CLARA, Calif., July 21, 2021 /PRNewswire/ -- Based on its recent analysis of the global AI-based Machine Health-as-a-Service market,Frost & Sullivan recognizes Augury, Inc. with t...

2021-07-21 20:00 846

Ascentage Pharma's MDM2-p53 Inhibitor APG-115 (Alrizomadlin) Granted an Orphan Drug Designation by the FDA for the Treatment of Stage IIB-IV Melanoma, Marking the Twelfth Obtained by the Company

SUZHOU, China and ROCKVILLE, Md., July 21, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the US Food and Drug Administration (F...

2021-07-21 18:37 2382

Clarivate Introduces Cortellis Supply Chain Network™, a Revolutionary Digital Partnering Solution

LONDON, July 21, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced the launch of theCortellis Supply Chain Network™, a part of the Cortellis suite of life science intelligence soluti...

2021-07-21 16:05 7446

Notice to the Annual General Meeting of Elekta AB (publ)

STOCKHOLM, July 21, 2021 /PRNewswire/ -- The shareholders of Elekta AB (publ), reg. no 556170-4015 are hereby convened to the Annual General Meeting to be held on Wednesday25 August 2021. Due to the coronavirus pandemic, the Board of Directors has decided that the Meeting should be conducted wit...

2021-07-21 15:06 7388

Knowledge Catalyst to Power Paspor Sehat in issuing Digital Health Credentials in Indonesia for Travelers

SINGAPORE, July 21, 2021 /PRNewswire/ -- Knowledge Catalyst, a recognized provider of Digital Health Credentials, also known as HealthCerts inSingapore, is proud to announce its partnership with Paspor Sehat, a recognized provider of the Electronic Health Alert Card (e-HAC) solution inIndonesi...

2021-07-21 14:00 854

MedPharm Implements the Peregrine Connect NetSuite PSA Add-in for Microsoft Project to Accurately Forecast Revenue and Cut Manual Labor by 80%

IRVINE, Calif., July 21, 2021 /PRNewswire/ -- Peregrine Connect's NetSuite PSA Add-in for Microsoft Project has been selected by MedPharm to forecast its revenue recognition for ongoing and completed business projects.  MedPharm is a world-leading contract development and manufacturing organizati...

2021-07-21 09:00 573

Synthetic Biology Startup Allozymes Raises US $5 Million Seed Round to Deliver Sustainable, Scalable Manufacturing of Natural Ingredients

* Responsible consumers and companies are increasingly unwilling to tolerate the significant environmental impacts associated with natural ingredients sourcing. * The startup, co-founded by scientist-entrepreneurs, Peyman Salehian, PhD and Akbar Vahidi, PhD, employs a unique technology platfor...

2021-07-21 07:18 1111

Direct Biologics Announces FDA Approval for Proceeding With Second ExoFlo IND for Post-Acute COVID-19 Syndrome and Chronic Post-COVID-19 Syndrome

Extracellular Vesicle Isolate Product ExoFlo Shows Strong Potential to Treat COVID-19, Post-Acute COVID-19 Syndrome, and Chronic Post-COVID-19 Syndrome; 60-patient trial to be conducted nationally at ambulatory infusion sites AUSTIN, Texas, July 21, 2021 /PRNewswire/ -- Direct Biologics, a marke...

2021-07-21 05:44 820

ExoFlo™ From Direct Biologics Fulfills Urgent Medical Need in COVID-19 Treatment

Medical professionals report dramatic and consistent success in treating patients gravely ill with COVID-19-associated Acute Respiratory Distress Syndrome (ARDS) AUSTIN, Texas, July 21, 2021 /PRNewswire/ -- As intensive care units across the country fill to capacity, hospital beds are in dangero...

2021-07-21 03:43 1041

OriCiro Announces ¥1 Billion Series B Financing to Advance Cell-Free DNA Technology for Innovative Therapeutics and Synthetic Biology

TOKYO, July 20, 2021 /PRNewswire/ -- OriCiro Genomics, a pioneer in cell-free synthesis and amplification of genome-scale large DNA for advanced therapy and synthetic biology, today announced that it has raised ¥800 million in Series B financing led by TheUniversity of Tokyo Edge Capital Partners...

2021-07-20 23:00 702

Terumo and UMCU strengthen their partnership to develop solutions in Interventional Oncology

LEUVEN, Belgium, July 20, 2021 /PRNewswire/ -- Terumo Europe and University Medical Center Utrecht (UMC Utrecht) announced today that they signed a Memorandum of Understanding (MoU) to recognize the longstanding partnership in the field of oncology. In the past years, both parties have successful...

2021-07-20 22:54 11540
12345678 ... 1046